Xtant Medical Holdings, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 6, 2026 (11 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 2, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 34% |
| May 13, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 31, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Nov 11, 2025 | BTIG | maintain | Buy → Buy | $1.5 | 52% |
| May 16, 2024 | BTIG | maintain | Buy → Buy | $3 | 52% |
| Dec 5, 2023 | BTIG | initiate | — → Buy | $2 | 52% |
| Jul 11, 2023 | Craig-Hallum | maintain | Buy → Buy | $1.2 | 54% |
| Apr 26, 2023 | Craig-Hallum | initiate | — → Buy | $1 | 54% |
| May 17, 2019 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| Dec 8, 2016 | Maxim Group | initiate | — → Buy | $2 | 42% |
| Nov 30, 2016 | Aegis Capital | initiate | — → Buy | $3.5 | — |
No cross-platform signals in the last 90 days